Lawrence J. DeLucas
Geschäftsführer bei PREDICTIVE ONCOLOGY INC.
Profil
Lawrence J.
DeLucas is the founder of Soluble Therapeutics, Inc. (founded in 2008) and Vivo Biosciences, Inc. (founded in 2004).
At Vivo Biosciences, he also held the title of Director.
Currently, he holds the position of Member-External Advisory Committee at Alabama State University (since 2004), Vice President-Operations at Predictive Oncology, Inc. (since 2021), and Member-Governors' Board at Indian Springs School (current).
In the past, he worked as Director at Cystic Fibrosis Foundation, Director-Biophysical Sciences & Engineering Center at The University of Alabama at Birmingham, and Director at TechBirmingham.
He was also the Chief Scientist at National Aeronautics & Space Administration (1995) and a Professor at UC Berkeley School of Optometry.
Dr. DeLucas's education history includes undergraduate (1972), graduate (1974), and doctorate (1982) degrees from The University of Alabama at Birmingham.
He also received an undergraduate degree from The University of Alabama at Birmingham in 1979.
Aktive Positionen von Lawrence J. DeLucas
| Unternehmen | Position | Beginn |
|---|---|---|
| PREDICTIVE ONCOLOGY INC. | Geschäftsführer | 01.06.2021 |
Vivo Biosciences, Inc.
 Vivo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Vivo Biosciences, Inc. develops platform for preclinical research, drug discovery and therapeutics. Its products include ready to use HuBiogel, angio-start assay kit, custom products, and mini-tumor assay plates. It also offers pre-clinical drug testing services, efficient 3D bioassay platform, and other HuBiogel applications. The company was founded by Lawrence J. DeLucas and Raj K. Singh in 2004 and is headquartered in Birmingham, AL. | Gründer | 01.01.2004 |
| Indian Springs School | Corporate Officer/Principal | 01.01.2003 |
| Alabama State University | Corporate Officer/Principal | 01.01.2004 |
Ehemalige bekannte Positionen von Lawrence J. DeLucas
| Unternehmen | Position | Ende |
|---|---|---|
| National Aeronautics & Space Administration | Technik-/Wissenschafts-/F&E-Leiter | 01.10.1995 |
| UC Berkeley School of Optometry | Corporate Officer/Principal | - |
Cystic Fibrosis Foundation
 Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Direktor/Vorstandsmitglied | - |
TechBirmingham
 TechBirmingham Information Technology ServicesTechnology Services TechBirmingham is an organization that serves as the voice of technology for the region. The company is based in Birmingham, AL. The company provides directories and aim to provide resources, support, and professional networking in a safe and affirming environment for LGBTQ members of central Alabama's tech community through their Tech Equals® initiative. The organization also spearheads larger community efforts around the issues that most impact the tech industry. The company was founded by James Wesley Childs. The CEO is Deon Gordon. | Direktor/Vorstandsmitglied | - |
Soluble Therapeutics, Inc.
 Soluble Therapeutics, Inc. BiotechnologyHealth Technology Soluble Therapeutics, Inc. engages in the design and development of formulations using HSC technology. Its services include initial, discovery, and formulation screening services. The company was founded by W. William Wilson and Lawrence J. DeLucas in 2008 and is headquartered in Birmingham, AL. | Gründer | - |
Ausbildung von Lawrence J. DeLucas
| The University of Alabama at Birmingham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| National Aeronautics & Space Administration | Government |
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Health Services |
Vivo Biosciences, Inc.
Vivo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Vivo Biosciences, Inc. develops platform for preclinical research, drug discovery and therapeutics. Its products include ready to use HuBiogel, angio-start assay kit, custom products, and mini-tumor assay plates. It also offers pre-clinical drug testing services, efficient 3D bioassay platform, and other HuBiogel applications. The company was founded by Lawrence J. DeLucas and Raj K. Singh in 2004 and is headquartered in Birmingham, AL. | Health Technology |
TechBirmingham
TechBirmingham Information Technology ServicesTechnology Services TechBirmingham is an organization that serves as the voice of technology for the region. The company is based in Birmingham, AL. The company provides directories and aim to provide resources, support, and professional networking in a safe and affirming environment for LGBTQ members of central Alabama's tech community through their Tech Equals® initiative. The organization also spearheads larger community efforts around the issues that most impact the tech industry. The company was founded by James Wesley Childs. The CEO is Deon Gordon. | Technology Services |
Soluble Therapeutics, Inc.
Soluble Therapeutics, Inc. BiotechnologyHealth Technology Soluble Therapeutics, Inc. engages in the design and development of formulations using HSC technology. Its services include initial, discovery, and formulation screening services. The company was founded by W. William Wilson and Lawrence J. DeLucas in 2008 and is headquartered in Birmingham, AL. | Health Technology |
